OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

Similar documents
NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS

THIN LAYER CHROMATOGRAPHY

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Title Revision n date

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Guide. homoeopathic preparations. for the elaboration of monographs on

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Lutein Esters from Tagetes Erecta

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

E17 ETHYLCELLULOSE. Revision 3 Stage 4

Draft proposal for The International Pharmacopoeia

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

Praveen U Sanganalmath, Yogaraje Gowda C V, Gowtham M D, Nayak V G, Mohan B M. Forensic Science Laboratory, Bangalore , Karnataka.

EMTRICITABINE AND TENOFOVIR TABLETS

Jagua (Genipin-Glycine) Blue (Tentative)

Heparin Sodium ヘパリンナトリウム

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Ergovaline. [Methods listed in the Feed Analysis Standards] 1 Liquid chromatography Note 1, 2 [Feed Analysis Standards, Chapter 5, Section 2

Unit I (b) Paper Chromatography

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

CLINDAMYCIN PALMITATE

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Antioxidant. [Summary of antioxidant]

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

TLC SEPARATION OF AMINO ACIDS

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

THERMALLY OXIDIZED SOYA BEAN OIL

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.

PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Phrmacognostical & Pharmaceutical study

FLUNITRAZEPAM Latest Revision: January 24, 2006

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

VOLUNTARY MONOGRAPH. Council for Responsible Nutrition March 2006

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

Neosolaniol. [Methods listed in the Feed Analysis Standards]

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Determination of Tanninoids. Analytical Pharmacognosy

APPLICATION OF TLC METHOD WITH VIDEO SCANNING IN ESTIMATION OF DAILY DIETARY INTAKE OF SPECIFIC FLAVONOIDS ñ PRELIMINARY STUDIES

EXPERIMENT 13: Isolation and Characterization of Erythrocyte

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

2 Avilamycin R 1. For chickens (except for broilers) Starting chicks Growing chicks. Starting broilers. Finishing broilers

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Revision Bulletin 28 Jul Aug 2017 Chemical Medicines Monographs 3

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

HEPARIN SODIUM. Heparinum natricum

15 Semduramicin sodium

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

The development of a detection method discriminating for

Chapter 4 Solvent-solvent separation

IJPRD, 2011; Vol 4(03): May-2012 ( ) International Standard Serial Number

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

Supporting Information. First synthetic entry to the trimer stage of 5,6-dihydroxyindole polymerization: orthoalkynylaniline-based

ISO INTERNATIONAL STANDARD. Animal and vegetable fats and oils Determination of individual and total sterols contents Gas chromatographic method

28 Lasalocid sodium OH O. Lasalocid C 34 H 54 O 8 MW: CAS No.:

E55A GELATIN, GELLING GRADE Gelatina

LC-MS/MS Method for the Determination of Tenofovir from Plasma

SECTION 1 LEARNING OBJECTIVES:

Supporting Information

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

13 Salinomycin Sodium

Transcription:

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS Nerium oleander ad praeparationes homoeopathicas Other Latin name used in homeopathy: Oleander DEFINITION Fresh leaf of Nerium oleander L. IDENTIFICATION A. The fresh leaf of oleander is entire, shortly petioled, lanceolate, measuring about 12 cm long and 2 cm large. It is green on the upper side; the underside is paler and shows a very conspicuous midrib of a whitish colour and numerous, secondary, parallel veins. It has a coriaceous consistency. B. Take a fragment of abaxial epidermis of the leaf. Examine under a microscope, using chloral hydrate solution R: epidermis composed of polyhedral cells and unicellular covering trichomes with strongly thickened and finely echinulate cell-wall; numerous openings corresponding to stomatiferous cavities, more or less ovoid, bordered by small cells markedly cuticle-covered and unicellular covering trichomes bent or hooked-shaped. TESTS Foreign matter (2.8.2): maximum 5 per cent. Loss on drying (2.2.32): minimum 50.0 per cent, determined on 5.0 g of finely-cut drug, by drying in an oven at 105 C for 2 h. STOCK DEFINITION Oleander mother tincture is prepared with ethanol (65 per cent V/V), using the fresh leaf of Nerium oleander L. Content: minimum 0.050 per cent m/m of total flavonoids, expressed as rutin (C 27 H 30 O 16, 3 H 2 O; M r 665).

2 PRODUCTION Method 4c (2371). Drug fragmented into 3-5 cm long segments. Maceration time: 3-5 weeks. CHARACTERS Brownish-green liquid. IDENTIFICATION Thin-layer chromatography (2.2.27). Test solution. Mother tincture. Reference solution. Dissolve 5 mg of rutin R and 5 mg of hyperoside R in 20 ml of ethanol (96 per cent) R. Plate: TLC silica gel plate R (5-40 µm) [or TCL silica gel plate R (2-10 µm)]. Mobile phase: anhydrous formic acid R, water R, ethyl acetate R (10:10:80 V/V/V). Application: 20 µl [or 10 µl] as bands. Development: over a path of 10 cm [or 6 cm]. Drying: in air. Detection: first spray with a 10 g/l solution of diphenylboric acid aminoethyl ester R in methanol R then with a 50 g/l solution of macrogol 400 R in methanol R. Allow the plate to dry in the air for about 30 min. Examine in ultraviolet light at 365 nm. Results: see below the sequence of fluorescent zones present in the chromatograms obtained with the reference solution and the test solution. Furthermore other faint fluorescent zones may be present in the chromatogram obtained with the test solution

3 Top of the plate A red zone An orange zone ------ ----- Hyperoside: an orange-yellow zone A blue zone A blue zone ------ ----- Rutin: an orange zone An orange zone (rutin) An orange zone Reference solution Test solution TESTS Ethanol content (2.9.10): 60 per cent V/V to 70 per cent V/V. Dry residue (2.8.16): minimum 1.5 per cent m/m. Oleandrine: maximum 0.030 per cent m/m. Liquid chromatography (2.2.29). Test solution. In a round-bottomed flask evaporate 1.250 g of mother tincture to dryness, under reduced pressure. Dilute the residue in 2.0 ml of methanol R. Reference solution. In a 50.0 ml volumetric flask, dissolve 15.0 mg of oleandrine R in methanol R and dilute to 50.0 ml with the same solvent. Place 7.0 ml of this solution into a 20.0 ml volumetric flask and dilute to 20.0 ml with methanol R. Column: - size: l = 0.25 m, Ø = 4.6 mm, - stationary phase: octylsilyl silica gel for chromatography R (5 µm), - temperature: 30 C. Mobile phase: - mobile phase A: water R, - mobile phase B: acetronitrile R. Time (min) 0 10 10 20 20 23 23 35 Mobile phase A (per cent V/V) 60 60 50 50 5 5 Mobile phase B (per cent V/V) 40 40 50 50 95 95

4 Flow rate: 1.0 ml/min. Detection: spectrophotometer at 220 nm. Injection: 10 µl. Calculate the percentage content m/m of oleandrine, from the expression: m 2 x A 1 x 0,014 x p m 1 x A 2 A 1 : area of the peak due to oleandrine in the chromatogram obtained with the test solution, A 2 : area of the peak due to oleandrine in the chromatogram obtained with the reference solution, m 1 : mass of the mother tincture sample in the test solution, in grams, m 2 : mass of oleandrine sample in the reference solution, in grams, p : percentage content of oleandrine in oleandrine R. ASSAY Ultraviolet and visible absorption spectrophotometry (2.2.25). Stock solution. Evaporate 1.500 g of mother tincture to dryness, under reduced pressure. Dissolve the residue in 25.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R. Test solution. Place 5 ml of stock solution into a 25.0 ml volumetric flask, add 5 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R. Then add 10 ml of a 25.0 g/l boric acid R and 20.0 g/l oxalic acid R solution in anhydrous formic acid R. Dilute to 25.0 ml with glacial acetic acid R. Compensation liquid of the test solution. Place 5 ml of stock solution into a 25.0 ml volumetric flask, add 5 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R. Then add 10 ml of anhydrous formic acid R. Dilute to 25.0 ml with glacial acetic acid R. Reference stock solution. In a 100.0 ml volumetric flask, dissolve 16.0 mg of rutin CRS in a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R. Dilute to 100.0 ml with the same mixture. In a 25.0 ml volumetric flask, place 5 ml of the solution and dilute to 25.0 ml with the same mixture. Reference solution. Place 10 ml of reference stock solution into a 25.0 ml volumetric flask, add 10.mL of a 25.0 g/l boric acid R and 20.0 g/l oxalic acid R solution in anhydrous formic acid R. Dilute to 25.0 ml with glacial acetic acid R. Compensation liquid of the reference solution. Place 10 ml of reference stock solution into a 25.0 ml volumetric flask, add 10 ml of anhydrous formic acid R. Dilute to 25.0 ml with glacial acetic acid R. Thirty min after the addition of the last reagent, measure the absorbance of the test solution at 420 nm, in comparison with the compensation liquid of the test solution, and the absorbance of the reference solution in comparison with the compensation liquid of the reference solution.

5 Calculate the percentage content m/m of total flavonoids, expressed as rutin, from the expression: A 1 x m 2 x p A 2 x m 1 x 10 A 1 = absorbance of the test solution, A 2 = absorbance of the reference solution, m 1 = mass of the mother tincture sample in the test solution, in grams, m 2 = mass of rutin sample in the reference solution, in grams, p = percentage content of rutin in rutin CRS.

6 Standard LC profiles of the test «Oleandrine» for information Standard LC profile of the reference solution Standard LC profile of the test solution